EP3268029

TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    11.3.2016
  • EP published:
    27.4.2022
  • EP application number:
    16711171.5
  • Max expiry date:
    10.3.2036
  • Title in English:
    TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS
  • Language of the patent:
    English

Timeline

Today
11.3.2016EP application
27.4.2022EP Publication

Owner

  • Name:
    Sanofi-Aventis Deutschland GmbH
  • Address:
    Brüningstraße 50, 65929 Frankfurt, DE

Inventor

  • Name:
    ROY, Christine
  • Address:
    75008 Paris, FR
  • Name:
    SOUHAMI, Elisabeth
  • Address:
    75008 Paris, FR
  • Name:
    DEMIL, Nacima
  • Address:
    75008 Paris, FR
  • Name:
    YE, Jenny
  • Address:
    New Jersey 08807, US

Priority

  • Number:
    15159064
  • Date:
    13.3.2015
  • Country:
    EP

Classification

  • Categories:
    A61K 38/28, A61K 31/155, A61P 3/10

Upload documents